Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “EORTC”

120 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 120 results

Large-scale testing (Phase 3)Study completedNCT00052299
What this trial is testing

Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
European Organisation for Research and Treatment of Cancer - EORTC 472
Not applicableUnknownNCT01838577
What this trial is testing

Genetics of EGFR (Epidermal Growth Factor Receptor) Mutation Study

Who this might be right for
EGFR Mutation Positive Non Small Cell Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 2,000
Not applicableStudy completedNCT07615218
What this trial is testing

Enhancing Cancer Care: Patient Navigation Through EORTC Quality-of-Life Insights at Sohag Oncology Center

Who this might be right for
Cancer CarePatient NavigationEORTC+2 more
Sohag Oncology Center 4,423
Not applicableLooking for participantsNCT06364579
What this trial is testing

Patient Reported Outcomes (PROs) in Anal Cancer Patient Treated by Intensity Modulated Radiotherapy (IMRT).

Who this might be right for
Anal Cancer Patients
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 120
Not applicableStudy completedNCT06842654
What this trial is testing

EORTC Quality of Life Measurement Strategies in Progressive Cancer

Who this might be right for
Cancer
University of Leeds 20
Not applicableUnknownNCT02858856
What this trial is testing

Clinical Trial of Sipjeondaebo-tang on Fatigue of Breast Cancer Patients

Who this might be right for
Breast Carcinoma
Kyunghee University Medical Center 48
Testing effectiveness (Phase 2)Study completedNCT02292979
What this trial is testing

Brentuximab Vedotin Associated With Chemotherapy in Untreated Patients With Hodgkin Lymphoma.

Who this might be right for
Hodgkin Lymphoma
The Lymphoma Academic Research Organisation 170
Large-scale testing (Phase 3)UnknownNCT01502696
What this trial is testing

Adjuvant PEG Intron in Ulcerated Melanoma

Who this might be right for
Ulcerated Melanomas
European Organisation for Research and Treatment of Cancer - EORTC 1,200
Not applicableUnknownNCT04656782
What this trial is testing

EORTC-endorsed, Prospective European Multicenter Imaging Survey and Protocol

Who this might be right for
Metastatic Colorectal Cancer
Ludwig-Maximilians - University of Munich 40
Not applicableUnknownNCT02979678
What this trial is testing

European Organisation of Research and Treatment (EORTC) Quality of Life Questionnaire (QLQ) Breast Cancer Module Update

Who this might be right for
Quality of Life
Medical University of Graz 260
Large-scale testing (Phase 3)WithdrawnNCT01652261
What this trial is testing

Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11)

Who this might be right for
Hodgkin Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC
Large-scale testing (Phase 3)UnknownNCT00017108
What this trial is testing

Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
European Organisation for Research and Treatment of Cancer - EORTC
Not applicableActive Not RecruitingNCT01101425
What this trial is testing

Male Breast Cancer: Understanding the Biology for Improved Patient Care

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 200
Large-scale testing (Phase 3)Study completedNCT00636168
What this trial is testing

Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma

Who this might be right for
High Risk Stage III Melanoma
Bristol-Myers Squibb 1,211
Large-scale testing (Phase 3)Active Not RecruitingNCT02799706
What this trial is testing

Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 885
Not applicableNot Yet RecruitingNCT07465133
What this trial is testing

Updating the EORTC Quality-of-Life Questionnaire for Ovarian Cancer (QLQ-OV38)

Who this might be right for
Ovarian CancerQuality of Life
Helios University Hospital Wuppertal 50
Testing effectiveness (Phase 2)Study completedNCT01538381
What this trial is testing

Neoadjuvant Afatinib Window Study in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
European Organisation for Research and Treatment of Cancer - EORTC 30
Testing effectiveness (Phase 2)UnknownNCT02436733
What this trial is testing

Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM

Who this might be right for
Malignant Pleural Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 64
Not applicableLooking for participantsNCT07315334
What this trial is testing

Assessing Functional Impairments in Patients With Chemotherapy-Induced Peripheral Neuropathy

Who this might be right for
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Paracelsus Medical University 120
Not applicableStudy completedNCT00564694
What this trial is testing

Studying a Quality of Life Questionnaire in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI) 350
Next Page